Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tezepelumab in severe uncontrolled asthma (NAVIGATOR)
NCT03347279Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2017
- Primary completion
- Sep 2020
- Modality
- Monoclonal Antibodies
- Countries
- 18
01
Overview
A Phase 3 trial of tezepelumab in asthma, sponsored by AstraZeneca. Started Nov 2017; status: completed.
02
Drugs
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03347279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03347279.